Sleep Number Receives Court Approval for Sale to Sleep Country Canada

Court approval meaningfully shifts SNBR from a going-concern story to a recovery-trade: the common is no longer pricing a turnaround, it is pricing residuality after a forced asset transfer. That typically compresses equity duration to the closing window; any incremental delay, administrative claim, or financing wrinkle pushes value toward zero faster than operating news can rebuild it. The market should treat post-approval rallies in the stock as liquidity-driven rather than fundamental, unless a disclosed cash recovery materially exceeds the liability stack.

The cleaner second-order winner is not the buyer so much as competitors with stable distribution and intact working capital cycles. A messy transition tends to hand share to incumbents in adjacent bedding and mattress channels, especially names with national retail reach and better vendor terms like TPX, while private-label suppliers can also absorb some displaced demand. If SNBR’s brand survives inside the buyer’s platform, that’s a medium-term competitive issue for everyone in the category, but in the next 1-3 months the more important effect is disruption: lost shopper traffic, cautious vendors, and potential channel reallocation.

Contrarian view: the consensus may be underestimating how little optionality remains for common equity once a court has effectively blessed a transfer of the operating business. The real tradable event is not the announcement itself but the gap between closing and final claims resolution; the thesis is falsified if the process produces an unexpectedly large equity recovery or if the closing slips materially, creating a squeeze in the distressed float. Time horizon matters: days for a headline bounce, 1-3 months for recovery math, and 6-18 months for competitive share shifts if the brand survives under new ownership.